06/02/2026
🧬 What is SPTLC2 Pediatric ALS?
Most people have never heard of SPTLC2—but for a few families, it is a life-altering reality.
SPTLC2 is an ultra-rare genetic condition caused by mutations in the SPTLC2 gene, which plays a critical role in sphingolipid metabolism. When this process is disrupted, toxic byproducts can build up and damage motor neurons—the nerve cells responsible for controlling movement.
For some children, this results in a childhood-onset form of ALS (Amyotrophic Lateral Sclerosis), often referred to as Juvenile ALS.
Symptoms may include:
🔹 Progressive muscle weakness
🔹 Difficulty walking or maintaining balance
🔹 Loss of motor function
🔹 Sensory abnormalities
🔹 Rapid disease progression
Because SPTLC2 Pediatric ALS is so rare, only a small number of cases have been identified worldwide. Many families spend years searching for answers, facing misdiagnoses, limited research, and a lack of clinical resources.
Rare diseases like SPTLC2 reveal critical gaps in healthcare, research, and diagnosis—especially for historically underrepresented communities who are often left out of genetic research and clinical studies.
At Melanin Children Matter Inc., we are committed to changing that reality through awareness, advocacy, research, and equity.
Every child deserves to be seen.
Every family deserves answers.
Every rare disease matters.
đź’™ In honor of the children and families affected by SPTLC2 Pediatric ALS, help us spread awareness by sharing this post.
